Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Traws Pharma, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 29 | 1 | 25 | −3 |
| Shares | 1.57M | 33 | 1.43M | −138.8K (−8.9%) |
| Value | $1.01M | $29 | $1.04M | +$32.5K (+3.2%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Traws Pharma, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 28,395 | $20.7K | 0.00% |
| Tower Research Capital LLC (TRC) | 5,245 | $4.00K | 0.00% |
| FMR LLC | 1 | $1 | 0.00% |
Sold out (6)
Institutions that held Traws Pharma, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Millennium Management LLC | 30,446 | $20.0K |
| Citadel Advisors LLC | 18,689 | $12.0K |
| Virtu Financial LLC | 16,982 | $11.0K |
| StoneX Group Inc. | 13,064 | $8.44K |
| Simplex Trading, LLC | 3,127 | $2.00K |
| Glassman Wealth Services | 133 | $86 |
Not filed for Q1 2023 yet (1)
Institutions that held Traws Pharma, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Cornerstone Planning Group LLC | 33 | $29 |